BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19584692)

  • 1. Effect of adherence to home spirometry on bronchiolitis obliterans and graft survival after lung transplantation.
    Kugler C; Fuehner T; Dierich M; DeWall C; Haverich A; Simon A; Welte T; Gottlieb J
    Transplantation; 2009 Jul; 88(1):129-34. PubMed ID: 19584692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
    Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
    Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
    Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redo lung transplantation for acute and chronic lung allograft failure: long-term follow-up in a single center.
    Osaki S; Maloney JD; Meyer KC; Cornwell RD; Edwards NM; De Oliveira NC
    Eur J Cardiothorac Surg; 2008 Dec; 34(6):1191-7. PubMed ID: 18774303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry.
    Hachem RR; Edwards LB; Yusen RD; Chakinala MM; Alexander Patterson G; Trulock EP
    Clin Transplant; 2008; 22(5):603-8. PubMed ID: 18435784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redo lung transplantation: a North American-European experience.
    Novick RJ; Kaye MP; Patterson GA; Andréassian B; Klepetko W; Menkis AH; McKenzie FN
    J Heart Lung Transplant; 1993; 12(1 Pt 1):5-15; discussion 15-6. PubMed ID: 8382951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
    Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
    J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation.
    Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
    Transplantation; 2003 Jun; 75(12):2064-8. PubMed ID: 12829913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation.
    Munster JM; van der Bij W; Breukink MB; van der Steege G; Zuurman MW; Hepkema BG; Verschuuren EA; van Son WJ; Seelen MA
    Transplantation; 2008 Dec; 86(12):1857-63. PubMed ID: 19104434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchoalveolar lavage fluid proteome in bronchiolitis obliterans syndrome: possible role for surfactant protein A in disease onset.
    Meloni F; Salvini R; Bardoni AM; Passadore I; Solari N; Vitulo P; Oggionni T; Viganò M; Pozzi E; Fietta AM
    J Heart Lung Transplant; 2007 Nov; 26(11):1135-43. PubMed ID: 18022079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.
    Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T
    Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seventy-two pulmonary retransplantations for obliterative bronchiolitis: predictors of survival.
    Novick RJ; Schäfers HJ; Stitt L; Andréassian B; Klepetko W; Hardesty RL; Frost A; Patterson GA
    Ann Thorac Surg; 1995 Jul; 60(1):111-6. PubMed ID: 7598570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.
    Reichenspurner H; Girgis RE; Robbins RC; Yun KL; Nitschke M; Berry GJ; Morris RE; Theodore J; Reitz BA
    Ann Thorac Surg; 1996 Nov; 62(5):1467-72; discussion 1472-3. PubMed ID: 8893585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchiolitis obliterans: the Achilles heel of lung transplantation.
    Frost AE
    Verh K Acad Geneeskd Belg; 2002; 64(5):303-19; discussion 319-22. PubMed ID: 12647579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary retransplantation: is it worth the effort? A long-term analysis of 46 cases.
    Aigner C; Jaksch P; Taghavi S; Lang G; Reza-Hoda MA; Wisser W; Klepetko W
    J Heart Lung Transplant; 2008 Jan; 27(1):60-5. PubMed ID: 18187088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
    Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
    Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.
    Davis RD; Lau CL; Eubanks S; Messier RH; Hadjiliadis D; Steele MP; Palmer SM
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):533-42. PubMed ID: 12658195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term health-related quality of life and walking capacity of lung recipients with and without bronchiolitis obliterans syndrome.
    Gerbase MW; Soccal PM; Spiliopoulos A; Nicod LP; Rochat T
    J Heart Lung Transplant; 2008 Aug; 27(8):898-904. PubMed ID: 18656804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.